![]() Eyenovia Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform. | ||||
Founding Date | Founding Date 2010 | Founding Date 2014 | Founding Date 2014 | Founding Date 2016 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Costa Mesa, US HQ | Locations Boston, US HQ | Locations New York, US HQ | Locations Baltimore, US HQ |
Employees | Employees 2 | Employees 802% decrease | Employees 22100% increase | Employees 2717% increase |
Financial | ||||
Net income | Net income ($4.9m) (FY, 2018) | Net income N/A | Net income ($45.3m) (FY, 2025) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 36m (almost 8 years ago) | Latest funding round N/A | Latest funding round $ 1.2m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 95m | Total funding raised N/A | Total funding raised $ 3.6m |
Emulate is a biotechnology company that specializes in organ-on-chips technology.
View company
Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform.
View company
CoapTech is a medical device company aiming to improve medical care delivery for patients.
View company